These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17158961)

  • 1. Bcl-xl does not have to bind Bax to protect T cells from death.
    Liu X; Zhu Y; Dai S; White J; Peyerl F; Kappler JW; Marrack P
    J Exp Med; 2006 Dec; 203(13):2953-61. PubMed ID: 17158961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
    Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
    J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BH3 domains other than Bim and Bid can directly activate Bax/Bak.
    Du H; Wolf J; Schafer B; Moldoveanu T; Chipuk JE; Kuwana T
    J Biol Chem; 2011 Jan; 286(1):491-501. PubMed ID: 21041309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
    Zhang J; Huang K; O'Neill KL; Pang X; Luo X
    Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.
    Willis SN; Fletcher JI; Kaufmann T; van Delft MF; Chen L; Czabotar PE; Ierino H; Lee EF; Fairlie WD; Bouillet P; Strasser A; Kluck RM; Adams JM; Huang DC
    Science; 2007 Feb; 315(5813):856-9. PubMed ID: 17289999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insight into BH3 domain binding of vaccinia virus antiapoptotic F1L.
    Campbell S; Thibault J; Mehta N; Colman PM; Barry M; Kvansakul M
    J Virol; 2014 Aug; 88(15):8667-77. PubMed ID: 24850748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax.
    McKenzie MD; Jamieson E; Jansen ES; Scott CL; Huang DC; Bouillet P; Allison J; Kay TW; Strasser A; Thomas HE
    Diabetes; 2010 Mar; 59(3):644-52. PubMed ID: 19959756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program.
    Ren D; Tu HC; Kim H; Wang GX; Bean GR; Takeuchi O; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
    Science; 2010 Dec; 330(6009):1390-3. PubMed ID: 21127253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis.
    Kim H; Tu HC; Ren D; Takeuchi O; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
    Mol Cell; 2009 Nov; 36(3):487-99. PubMed ID: 19917256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BimL directly neutralizes Bcl-xL to promote Bax activation during UV-induced apoptosis.
    Wang X; Xing D; Liu L; Chen WR
    FEBS Lett; 2009 Jun; 583(12):1873-9. PubMed ID: 19427863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BH3-only protein Bim inhibits activity of antiapoptotic members of Bcl-2 family when expressed in yeast.
    Juhásová B; Mentel M; Bhatia-Kiššová I; Zeman I; Kolarov J; Forte M; Polčic P
    FEBS Lett; 2011 Sep; 585(17):2709-13. PubMed ID: 21820438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIM-mediated membrane insertion of the BAK pore domain is an essential requirement for apoptosis.
    Weber K; Harper N; Schwabe J; Cohen GM
    Cell Rep; 2013 Oct; 5(2):409-20. PubMed ID: 24120870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.
    Goodwin CM; Rossanese OW; Olejniczak ET; Fesik SW
    Cell Death Differ; 2015 Dec; 22(12):2098-106. PubMed ID: 26045046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism.
    Pei XY; Dai Y; Tenorio S; Lu J; Harada H; Dent P; Grant S
    Blood; 2007 Sep; 110(6):2092-101. PubMed ID: 17540843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interconnected hierarchical model of cell death regulation by the BCL-2 family.
    Chen HC; Kanai M; Inoue-Yamauchi A; Tu HC; Huang Y; Ren D; Kim H; Takeda S; Reyna DE; Chan PM; Ganesan YT; Liao CP; Gavathiotis E; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2015 Oct; 17(10):1270-81. PubMed ID: 26344567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S; Choi M; Baek K; Yoon HS
    Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct lipid effects on tBid and Bim activation of membrane permeabilization by pro-apoptotic Bax.
    Shamas-Din A; Bindner S; Chi X; Leber B; Andrews DW; Fradin C
    Biochem J; 2015 May; 467(3):495-505. PubMed ID: 25714678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
    Jiang X; Tsang YH; Yu Q
    Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitor.
    Gomez JA; Sun W; Gama V; Hajkova D; Yoshida T; Wu Z; Miyagi M; Pink JJ; Jackson MW; Danielpour D; Matsuyama S
    Cancer Biol Ther; 2009 Sep; 8(18):1771-86. PubMed ID: 19657228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.